Josep Tabernero, M.D., Ph.D.

Dr. Tabernero currently serves as Head of the Medical Oncology Department at the Vall d’Hebron Barcelona Hospital and the Director of the Vall d’Hebron Institute of Oncology. His research group aims at potentiating molecular therapies targeting specific oncoproteins and accelerating more effective personalized cancer medicines for patients displaying genetic lesions or pathway dysregulation. Dr. Tabernero has held leadership positions in many other organizations devoted to advancing cancer research, including Past President of the European Society for Medical Oncology (ESMO) from 2018-2019. He holds M.D. and Ph.D. degrees from the Universitat Autònoma de Barcelona, Spain.